Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomiib and Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma


Collapse Overview 
Collapse sponsor award id
M15-538


Collapse Biography 

Collapse Time 
Collapse start date
2017-05-30